You are here

  • Home
  • Archive
  • Volume 2, Issue Suppl 2
  • P19. Immunomodulation of blasts in AML-patients (pts) with clinically approved response modifiers to improve anti leukaemic T-cell reactivity: an ex vivo simulation of the clinical situation

Article metrics

Article menu

Download PDFPDF

Poster Presentation
P19. Immunomodulation of blasts in AML-patients (pts) with clinically approved response modifiers to improve anti leukaemic T-cell reactivity: an ex vivo simulation of the clinical situation

 

Online download statistics by month:

Online download statistics by month: December 2019 to August 2024

AbstractFullPdf
Dec 2019010
Jan 2020031
Feb 2020031
May 2020040
Jun 2020070
Jul 2020030
Aug 2020010
Sep 2020060
Nov 2020010
Dec 2020021
Jan 2021010
Mar 2021031
Apr 2021030
May 2021010
Jun 2021030
Jul 2021060
Aug 2021010
Sep 2021020
Oct 2021040
Nov 2021034
Dec 2021040
Jan 2022020
Feb 2022010
Mar 2022020
May 2022061
Jun 2022031
Jul 2022041
Aug 2022063
Sep 2022031
Oct 2022044
Nov 2022021
Dec 2022040
Jan 2023031
Feb 2023020
Mar 2023020
Apr 2023011
Jun 2023010
Jul 2023011
Aug 2023001
Sep 2023031
Oct 2023001
Nov 2023031
Dec 2023041
Jan 2024011
Feb 2024043
Mar 20240815
Apr 2024046
May 2024044
Jun 2024020
Jul 2024050
Aug 2024021
Total014958